International genomics consortium, the:1181225 [16-007894]

Ended Awarded Jan 15, 2016 Last action Sep 2, 2021

Contract number: HHSN26100001
Awardee: The International Genomics Consortium UEI NUGSVF3J2252
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $0

Award facts

Opportunity: N02CO5441602 Solicitation number

Full and Open Competition Tissue Purchase Order Acquisitions for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) Award Notice · Posted Jul 30, 2015
Contract value: $0.00 Current and potential, with all options
Completion date 100% complete: Jan 14, 2019 Current and potential, with all options
NAICS code: 325413 In-Vitro Diagnostic Substance Manufacturing
PSC: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside: No set-aside
Competition: Competed under SAP Simplified Acquisition
Pricing: Firm Fixed Price
Place of performance: Phoenix, AZ 85004, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Funding Only Action P00003 · DE-obligation of funds from FY2016 expiring lines.	-$221,340	Sep 2, 2021
Funding Only Action 2	$11,900	Jan 12, 2018
Other Administrative Action 1	$23,800	Jan 13, 2017
Original award	$185,640	Jan 15, 2016

HHSN26100001 was awarded to The International Genomics Consortium by National Cancer Institute (National Institutes of Health) on January 15, 2016.

The government has obligated $0 on HHSN26100001.

Yes. HHSN26100001 is a delivery order under HHSN261201600003I, an indefinite delivery contract, on Tissue Source Site for Tumor Analysis.

The extent of competition for HHSN26100001 was competed under sap.

On GovTribe

Try for free Login